Christy Nebesio, MD
Dermatology · Indianapolis, INNPI 1144222910
Payments from drug & device makers
Across 650 payments — averaging $15.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- Pfizer$818
- Lilly USA, LLC$724
- Incyte Corporation$656
- Johnson & Johnson$597
- plus $4K from 24 others
What the payments were for
- Food & beverage$9,97097%
- Education$3343%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 126 | $2,172 |
| Novartis | 180 | $1,472 |
| Pfizer | 55 | $818 |
| Lilly USA, LLC | 36 | $724 |
| Incyte Corporation | 30 | $656 |
| Johnson & Johnson | 19 | $597 |
| E.r. Squibb & Sons, L.L.C. | 35 | $537 |
| Regeneron Healthcare Solutions, Inc. | 15 | $528 |
| Amgen | 25 | $390 |
| Dermavant Sciences, Inc. | 21 | $367 |
| UCB, Inc. | 15 | $336 |
| Sun Pharmaceutical Industries Inc. | 23 | $334 |
| Galderma Laboratories, L.p. | 14 | $262 |
| Mayne Pharma Commercial LLC | 15 | $191 |
| Arcutis Biotherapeutics, Inc. | 2 | $156 |
| Boehringer Ingelheim | 5 | $153 |
| LEO Pharma Inc. | 7 | $113 |
| Stemline Therapeutics Inc. | 1 | $112 |
| Sanofi | 4 | $80 |
| Bristol Myers Squibb | 5 | $65 |
| Botanix SB Inc | 3 | $65 |
| Organon | 4 | $56 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $29 |
| VYNE Pharmaceuticals Inc. | 1 | $18 |
| Fresenius Kabi USA, LLC | 1 | $15 |
| DUSA Pharmaceuticals, Inc. | 1 | $14 |
| Dermira, Inc. | 1 | $14 |
| Biofrontera Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
| Prugen, Inc. Pharmaceuticals | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,304 in reported general payments places this provider in the 70th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 15 | $113,525 |
| Dupixent PenDupilumab | 26 | $97,087 |
| Clobetasol Propionate | 162 | $8,053 |
| Fluorouracil | 86 | $6,841 |
| Ketoconazole | 255 | $4,143 |
| Metronidazole | 36 | $2,133 |
| ValacyclovirValacyclovir Hcl | 63 | $1,349 |
| Spironolactone | 29 | $1,072 |
| Triamcinolone Acetonide | 127 | $1,016 |
| Dutasteride | 40 | $938 |
| Doxycycline Hyclate | 28 | $899 |
| Desoximetasone | 14 | $806 |
| Minoxidil | 25 | $457 |
| Minocycline Hcl | 27 | $441 |
| Hydroxychloroquine Sulfate | 15 | $368 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Indianapolis
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Kenneth DawesIndianapolis$2.2M
- Ginat MirowskiIndianapolis$1.8M
- Christopher ObeimeIndianapolis$907K
- Priya YoungIndianapolis$492K
- Nikolajs PerdueIndianapolis$302K
- Matthew TurnerIndianapolis$203K
- Stephen WolvertonIndianapolis$29K
- Annette DinneenIndianapolis$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.